Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Showing 26-50 of 74 citing articles:

Potential Therapeutic Effects of Psilocybin: A Systematic Review
Dev B Goel, Sarju Zilate
Cureus (2022)
Open Access | Times Cited: 13
Psychedelic-Assisted Psychotherapy and Mindfulness-Based Cognitive Therapy: Potential Synergies
Richard Chambers, Devon Stoliker, Otto Simonsson
Mindfulness (2023) Vol. 14, Iss. 9, pp. 2111-2123
Open Access | Times Cited: 7
Can Psychedelic Use Benefit Meditation Practice? Examining Individual, Psychedelic, and Meditation-Related Factors
Zishan Jiwani, Simon B. Goldberg, Jack Stroud, et al.
medRxiv (Cold Spring Harbor Laboratory) (2024)
Open Access | Times Cited: 2
Meditating on psychedelics. A randomized placebo-controlled study of DMT and harmine in a mindfulness retreat
Daniel Meling, Klemens Egger, Helena D. Aicher, et al.
Journal of Psychopharmacology (2024)
Closed Access | Times Cited: 2
The Psychedelic Integration Scales: Tools for Measuring Psychedelic Integration Behaviors and Experiences
Tomas Frymann, Sophie Whitney, David B. Yaden, et al.
Frontiers in Psychology (2022) Vol. 13
Open Access | Times Cited: 12
The Impact of Psilocybin on Patients Experiencing Psychiatric Symptoms: A Systematic Review of Randomized Clinical Trials.
Waguih William IsHak, Paloma García, Rachel Pearl, et al.
PubMed (2023) Vol. 20, Iss. 4-6, pp. 39-48
Closed Access | Times Cited: 6
Insights, Life Changes and Lifestyle Changes Reported by Individuals Consuming Ayahuasca in Naturalistic Settings: Nature, Frequency and Associations with Mental Health and Wellbeing
Daniel Perkins, Emérita Sátiro Opaleye, José Carlos Bouso, et al.
Psychoactives (2023) Vol. 2, Iss. 4, pp. 256-286
Open Access | Times Cited: 6
Psychedelics and psychological strengths
Trey Brasher, David S. Rosen, Marcello Spinella
International Journal of Wellbeing (2023) Vol. 13, Iss. 1, pp. 1-35
Open Access | Times Cited: 5
Mystical Experience
Johannes Bronkhorst
Religions (2022) Vol. 13, Iss. 7, pp. 589-589
Open Access | Times Cited: 8
Virtual Reality and Psychedelics for the Treatment of Psychiatric Disease: A Systematic Literature Review.
Federico J. Gómez-Busto, Mario I. Ortíz
PubMed (2020) Vol. 17, Iss. 6, pp. 365-380
Closed Access | Times Cited: 12
Therapeutic Potential of Psilocybin for Treating Psychological Distress among Survivors of Adverse Childhood Experiences: Evidence on Acceptability and Potential Efficacy of Psilocybin Use
Kiffer G. Card, Ashmita Grewal, Kalysha Closson, et al.
Journal of Psychoactive Drugs (2023), pp. 1-11
Closed Access | Times Cited: 4
Psilocybin for Opioid Use Disorder in Two Adults Stabilized on Buprenorphine: A Technical Report on Study Modifications and Preliminary Findings
Christopher R. Nicholas, David Horton, Julia Malicki, et al.
Psychedelic Medicine (2023) Vol. 1, Iss. 4, pp. 253-261
Closed Access | Times Cited: 4
Chronic pain as an emergent property of a complex system and the potential roles of psychedelic therapies
Maya Armstrong, Joel Castellanos, Devon Christie
Frontiers in Pain Research (2024) Vol. 5
Open Access | Times Cited: 1
How Does Psilocybin Therapy Work? an Exploration of Experiential Avoidance as a Putative Mechanism of Change
Richard J. Zeifman
(2024)
Open Access | Times Cited: 1
Exploring symptom clusters in Chinese patients with peritoneal dialysis: a network analysis
Di-Fei Duan, Xueli Zhou, Yan Yu, et al.
Renal Failure (2024) Vol. 46, Iss. 1
Open Access | Times Cited: 1
Psychedelic Microdosing, Mindfulness, and Anxiety: A Cross-Sectional Mediation Study
Vincent Hartong, Arnold van Emmerik
Journal of Psychoactive Drugs (2022) Vol. 55, Iss. 3, pp. 310-320
Open Access | Times Cited: 7
Altered states of leadership: mindfulness meditation, psychedelic use, and leadership development
Otto Simonsson, Cecilia U. D. Stenfors, Simon B. Goldberg, et al.
Frontiers in Psychology (2023) Vol. 14
Open Access | Times Cited: 3
A continuum hypothesis of psychotomimetic rapid antidepressants
Joost Haarsma, Catherine J. Harmer, Sandra Tamm
Brain and Neuroscience Advances (2021) Vol. 5
Open Access | Times Cited: 8
Psychédéliques, psychothérapie et symbolisation : une revue de littérature dans le champ de la dépression
Etienne Artru, Thomas Rabeyron
L Évolution Psychiatrique (2021) Vol. 86, Iss. 3, pp. 591-616
Open Access | Times Cited: 7
Therapeutic Use of Hallucinogens
Victor Distefano Wiltenburg, Dianne da Rocha Prado, Fúlvio Rieli Mendes
Springer eBooks (2021), pp. 479-510
Closed Access | Times Cited: 6
Neural Mechanisms and Psychology of Psychedelic Ego Dissolution
Devon Stoliker, Gary F. Egan, Karl Friston, et al.
(2021)
Open Access | Times Cited: 6
Attention
Aidan Lyon
Oxford University Press eBooks (2023), pp. 94-129
Closed Access | Times Cited: 2
Combinatorial approaches for treating neuropsychiatric social impairment
Wei Don, Sherab Tsheringla, James C. McPartland, et al.
Philosophical Transactions of the Royal Society B Biological Sciences (2022) Vol. 377, Iss. 1858
Open Access | Times Cited: 4
Psilocybin and the Meaning Response: Exploring the Healing Process in a Retreat Setting in Jamaica
María de Ángeles Equihua Orozco, Shana Harris
Anthropology of Consciousness (2022) Vol. 34, Iss. 1, pp. 130-160
Closed Access | Times Cited: 4
New Insights Into the Clinical and Nonclinical Effects of Psychedelic Substances
Matthias Forstmann, Christina Sagioglou
European Psychologist (2021) Vol. 27, Iss. 4, pp. 291-301
Closed Access | Times Cited: 5

Scroll to top